Visualization of nonsmall-cell lung cancer by near-infrared fluorescence imaging with tumor-targeting peptide ABT-510
View abstract on PubMed
Summary
This summary is machine-generated.A novel near-infrared fluorescent probe, MPA-ABT-510, targets CD36 for improved nonsmall-cell lung cancer (NSCLC) visualization. This probe shows high tumor accumulation and strong binding affinity, aiding in surgical navigation for NSCLC patients.
Area Of Science
- Oncology
- Medical Imaging
- Molecular Biology
Background
- Nonsmall-cell lung cancer (NSCLC) is the most common lung malignancy.
- Accurate visualization of NSCLC is crucial for effective surgical treatment.
- Current imaging methods face challenges due to lung anatomy and respiratory motion.
Purpose Of The Study
- To investigate CD36 as a potential imaging target for NSCLC.
- To develop and evaluate a novel near-infrared (NIR) fluorescent probe for NSCLC.
- To assess the probe's efficacy in vitro and in vivo for NSCLC detection and surgical navigation.
Main Methods
- Constructed a water-soluble NIR fluorescent probe, MPA-ABT-510, by conjugating ABT-510 with MPA.
- Performed molecular docking to predict binding affinity to CD36.
- Conducted in vitro cell binding assays using NSCLC cell lines (H1299, A549).
- Evaluated in vivo tumor targeting and accumulation using subcutaneous and orthotopic mouse models.
- Assessed biodistribution in liver and intestinal metastasis models.
Main Results
- MPA-ABT-510 demonstrated strong binding affinity to CD36 via molecular docking.
- In vitro assays confirmed specific binding of ABT-510 to CD36-high NSCLC cells.
- In vivo imaging showed efficient accumulation of MPA-ABT-510 in NSCLC tumor sites.
- High tumor-to-lung and tumor-to-liver fluorescence ratios were observed in metastasis models.
- Significant accumulation was noted in intestinal metastasis models.
Conclusions
- MPA-ABT-510 is a selective and effective fluorescent probe for NSCLC.
- The probe exhibits excellent imaging capabilities with minimal safety concerns.
- MPA-ABT-510 holds promise as a tool for NSCLC surgical navigation.

